Showing results (1851-1860 of 2,887) with videos related to

Sort By:
Pageof 289
Environmental Toxicology and Chemistry|April 6, 2011
Environmental fractionation of PCBs and PBDEs during particle transport as recorded by sediments in coastal watersPaul B C Grant, Sophia C Johannessen, Robie W Macdonald, et al.
Annals of Internal Medicine|January 4, 2012
Comparison of hospital risk-standardized mortality rates calculated by using in-hospital and 30-day models: an observational study with implications for hospital profilingElizabeth E Drye, Sharon-Lise T Normand, Yun Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 4, 2011
Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cellsKelly A Holmes, Antoni Hurtado, Gordon D Brown, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|March 11, 2015
The relationship between population-level exposure to alcohol advertising on television and brand-specific consumption among underage youth in the USCraig S Ross, Emily Maple, Michael Siegel, et al.
The Journal of Urology|October 27, 2012
Vasectomy: AUA guidelineIra D Sharlip, Arnold M Belker, Stanton Honig, et al.
Scientific Data|August 8, 2023
Clinical trial data sharing: a cross-sectional study of outcomes associated with two U.S. National Institutes of Health modelsAnisa Rowhani-Farid, Mikas Grewal, Steven Solar, et al.
Ophthalmic Plastic and Reconstructive Surgery|June 5, 1998
Silicon granulomas and dermatomyositis-like changes associated with chronic eyelid edema after silicone breast implantD R Meyer, H X Bui, J A Carlson, et al.
Ebiomedicine|May 30, 2015
Use of Whole Genome Sequencing for Diagnosis and Discovery in the Cancer Genetics ClinicSamantha B Foley, Jonathan J Rios, Victoria E Mgbemena, et al.
Archives of Pathology & Laboratory Medicine|October 25, 2019
Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Updates on HER2 Assessment in Breast Cancer With Equivocal HER2 Immunohistochemistry Results With Focus on Cases With <i>HER2</i>/CEP17 Ratio <2.0 and Average <i>HER2</i> Copy Number ≥4.0 and <6.0Raza S Hoda, Edi Brogi, Jin Xu, et al.
BMJ (Clinical Research Ed.)|August 3, 2018
Trends in opioid use in commercially insured and Medicare Advantage populations in 2007-16: retrospective cohort studyMolly Moore Jeffery, W Michael Hooten, Henry J Henk, et al.
Pageof 289